澳门太阳游戏城app官网入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Identification of Filamin-A and-B as potential biomarkers for prostate cancer.

Future Sci.. 2016-12; 
Niven R Narain??, Anne R Diers??, Arleide Lee??, Socheata Lao??, Joyce Y Chan??, Sally Schofield??, Joe Andreazi??, Rakibou Ouro-Djobo??, Joaquin J Jimenez??, Tracey Friss??, Nikunj Tanna??, Aditee Dalvi??, Sihe Wang??, Dustin Bunch??, Yezhou Sun??, Wenfang Wu??, Khampaseuth Thapa??, Stephane Gesta??, Leonardo O Rodrigues??, Viatcheslav R Akmaev??, Vivek K Vishnudas?? & Rangaprasad Sarangarajan??.
Products/Services Used Details Operation

摘要


Aim:
A novel strategy for prostate cancer (PrCa) biomarker discovery is described.
Materials & methods:
In vitro perturbation biology, proteomics and Bayesian causal analysis identified biomarkers that were validated in in vitro models and clinical specimens.
Results:
Filamin-B (FLNB) and Keratin-19 were identified as biomarkers. Filamin-A (FLNA) was found to be causally linked to FLNB. Characterization of the biomarkers in a panel of cells revealed differential mRNA expression and regulation. Moreover, FLNA and FLNB were detected in the conditioned media of cells. Last, in patients without PrCa, FLNA and FLNB blood levels were positively correlated, while in p... More

关键词